The combination of low hemoglobin, marked microcytosis, hypochromia and increased RDW is most consistent with iron-deficiency anemia. Pica and heavy menstrual bleeding further support the diagnosis. ● B: Anemia of inflammation may be microcytic, but RDW elevation and the bleeding history more strongly suggest iron deficiency. ● C: Thalassemia trait often produces marked microcytosis with a relatively preserved RBC count and less RDW elevation. ● D: Vitamin B12 deficiency ordinarily causes macrocytosis.

Ferritin is the most useful initial measure of iron stores. A low ferritin strongly supports iron deficiency. Because ferritin is an acute-phase reactant, a normal or elevated value may not exclude iron deficiency when inflammation is present.

Iron deficiency reduces circulating iron and transferrin saturation. The liver generally increases transferrin production, producing an elevated total iron-binding capacity.

Treatment must address both the deficiency and its cause. Heavy menstrual bleeding should be investigated rather than repeatedly replacing iron without controlling the blood loss.

Macro-ovalocytes, hypersegmented neutrophils, neurologic symptoms and mild involvement of multiple cell lines indicate megaloblastic anemia due to vitamin B12 deficiency.

Methylmalonic acid generally rises in functional vitamin B12 deficiency and can clarify an indeterminate serum B12 result. Renal dysfunction can also elevate methylmalonic acid and must be considered during interpretation.

The autoimmune history and adequate dietary intake suggest autoimmune gastritis with impaired intrinsic-factor function. Anti-intrinsic-factor antibody testing is appropriate when autoimmune gastritis is suspected.

Neurologic manifestations increase the urgency of replacement. Treatment should not be unnecessarily delayed while awaiting every etiologic test. Folate alone may improve hematologic findings without appropriately treating the neurologic consequences of vitamin B12 deficiency.

High reticulocytes, elevated LDH, elevated indirect bilirubin and low haptoglobin constitute a hemolysis pattern. The marrow is responding by releasing increased numbers of reticulocytes.

The direct antiglobulin test detects immunoglobulin or complement attached to circulating red blood cells and helps identify autoimmune hemolytic anemia.

Reticulocytosis can increase the measured MCV because reticulocytes are larger than mature red blood cells.

Symptomatic, rapidly progressive hemolysis can produce severe anemia and cardiovascular compromise. Urgent evaluation is required to determine the need for immunosuppressive treatment, transfusion or management of an underlying trigger.

All three major cell lines are reduced: red blood cells, white blood cells and platelets.

The result should be verified, and the smear should be examined for blasts, dysplastic cells, schistocytes, macro-ovalocytes or other diagnostic clues.

Multilineage cytopenia with blasts or dysplasia raises concern for leukemia, myelodysplastic syndrome or another marrow disorder. Definitive evaluation generally requires bone-marrow examination.

Fever with marked neutropenia is an emergency because serious infection can progress rapidly despite subtle physical findings. Unexplained bleeding or abnormal counts also warrant urgent evaluation for hematologic malignancy.

Warfarin reduces vitamin K–dependent coagulation factors and is routinely monitored using the prothrombin time standardized as the INR.

Melena, symptomatic anemia, hypotension and an INR of 7.2 indicate clinically significant bleeding in an excessively anticoagulated patient.

Major warfarin-associated bleeding requires urgent stabilization, control of the bleeding source and anticoagulant reversal. Four-factor prothrombin-complex concentrate with intravenous vitamin K is commonly used in emergency reversal protocols.

Several antimicrobials can potentiate warfarin through metabolic interactions or alteration of vitamin K availability. New medications should be reviewed whenever an INR becomes unexpectedly elevated.

DIC causes systemic activation of coagulation with consumption of platelets and clotting factors. Typical findings include thrombocytopenia, prolonged coagulation times, reduced fibrinogen and elevated fibrin-degradation products.

Immune thrombocytopenia generally produces isolated thrombocytopenia. PT, aPTT and fibrinogen are usually unaffected unless another coagulation disorder is present.

DIC cannot be controlled reliably without treating the precipitating condition. Blood products and other supportive interventions are individualized according to bleeding, laboratory values and planned procedures.

DIC evolves over time. Serial trends are generally more informative than one isolated set of results.

The sodium is low and the measured serum osmolality is below normal, confirming true hypotonic hyponatremia.

Euvolemic hypotonic hyponatremia with inappropriately concentrated urine, elevated urine sodium and exclusion of major thyroid and adrenal causes is consistent with SIADH. Medications, including some antidepressants, may precipitate this pattern.

Confusion with a sodium of 118 mmol/L represents symptomatic severe hyponatremia. The patient requires urgent monitored treatment, assessment of duration and management of the precipitating cause. Serious neurologic symptoms can occur when sodium is very low or decreases rapidly.

Chronic or duration-unknown hyponatremia must be corrected carefully. Excessively rapid correction can cause severe neurologic injury.

Hemolysis can produce pseudohyperkalemia, but a potentially dangerous value should not simply be dismissed. The potassium should be repeated urgently with proper collection, and cardiac electrical effects should be assessed. A nonhemolyzed repeat sample shows potassium of 6.8 mmol/L. The ECG demonstrates peaked T waves and QRS widening.

Intravenous calcium stabilizes the cardiac membrane when hyperkalemia produces significant ECG abnormalities. It does not substantially lower the serum potassium.

Insulin temporarily lowers extracellular potassium by promoting cellular uptake. Blood glucose must be monitored because treatment can cause hypoglycemia.

Calcium stabilizes the myocardium, while insulin temporarily redistributes potassium. In severe refractory hyperkalemia with renal failure, dialysis may be required to remove potassium from the body.

Fluid loss, a relatively high BUN-to-creatinine ratio, concentrated urine and low urine sodium support a prerenal pattern. NSAID use and renin-angiotensin-system blockade can further impair renal autoregulation during volume depletion.

Management should correct the precipitating volume loss and temporarily address medications that worsen renal perfusion or electrolyte abnormalities. Urine output, creatinine and potassium require close monitoring.

Hematuria with dysmorphic red cells, red-cell casts and proteinuria suggests a glomerular source and warrants focused nephrologic investigation. At follow-up, kidney function improves but remains abnormal. Three months later, the eGFR is 53 mL/min/1.73 m² and the urine albumin-to-creatinine ratio is 120 mg/g.

An eGFR of 45–59 corresponds to G3a, and an albumin-to-creatinine ratio of 30–300 mg/g corresponds to A2. Persistence for at least three months supports CKD rather than isolated AKI. KDIGO recommends classifying CKD using cause, GFR category and albuminuria category.

Alkaline phosphatase is disproportionately elevated relative to AST and ALT. Elevated GGT supports a hepatobiliary source of the alkaline-phosphatase elevation. Direct hyperbilirubinemia is consistent with impaired bile flow.

Ultrasonography can evaluate the gallbladder, bile ducts and liver and determine whether biliary dilation suggests an extrahepatic obstruction.

AST, ALT, alkaline phosphatase and GGT primarily indicate patterns of injury or cholestasis. Albumin and PT/INR help assess hepatic protein synthesis, although albumin changes more slowly and can be affected by nonhepatic conditions. Ultrasonography demonstrates a dilated common bile duct. The patient subsequently develops fever, hypotension and confusion.

Obstructive findings accompanied by fever, hypotension and altered mental status suggest severe ascending cholangitis with potential sepsis. Urgent antimicrobial treatment, stabilization and biliary decompression may be required.

An elevated TSH with a reduced free T4 indicates primary thyroid-gland failure. Why the other options are incorrect ● A: Central hypothyroidism usually produces a low or inappropriately normal TSH with a low free T4. ● C: Subclinical hyperthyroidism produces a low TSH with normal thyroid-hormone levels. ● D: Severe nonthyroidal illness can alter thyroid tests, but the clinical presentation and markedly elevated TSH favour primary hypothyroidism.

Thyroid peroxidase antibodies are commonly present in autoimmune thyroiditis and support Hashimoto thyroiditis as the cause. ● A: TSH-receptor antibodies are primarily associated with Graves disease. ● B: Thyroglobulin alone does not establish autoimmune hypothyroidism. ● C: Calcitonin is used primarily when medullary thyroid carcinoma is suspected.

TSH requires several weeks to reach a new steady state after levothyroxine initiation or a dosage adjustment. ● B: One day is too early to assess the full effect. ● C: Waiting one year risks prolonged under- or overtreatment. ● D: Biochemical monitoring is needed even when symptoms are nonspecific.

These findings suggest myxedema coma, a life-threatening form of severe hypothyroidism requiring emergency treatment.

Diffuse thyroid enlargement, biochemical hyperthyroidism and eye findings strongly suggest Graves disease. ● A: Toxic multinodular goitre is more commonly nodular and generally does not cause thyroid eye disease. ● B: Subacute thyroiditis typically causes thyroid pain and transient hormone release. ● D: TSH-secreting pituitary disease usually causes an inappropriately normal or elevated TSH.

TSH-receptor antibodies stimulate the thyroid and are highly supportive of Graves disease. ● B: Thyroid peroxidase antibodies may occur in several autoimmune thyroid conditions. ● C: Calcitonin is associated with medullary thyroid carcinoma assessment. ● D: Parathyroid hormone evaluates calcium and parathyroid disorders.

Radioactive iodine testing is contraindicated during pregnancy because the radioactive material can cross the placenta and affect the fetal thyroid. ● A: Ultrasound does not use ionizing radiation. ● B: Thyroid-function testing is appropriate during pregnancy. ● C: Antibody testing may help assess maternal and fetal risk.

Hyperthermia, severe tachyarrhythmia, gastrointestinal symptoms and altered mental status suggest thyroid storm.

Low cortisol with elevated ACTH, hyperpigmentation, hyponatremia and hyperkalemia indicates primary adrenal-gland failure. ● B: Secondary adrenal insufficiency usually has low or inappropriately normal ACTH and generally does not cause significant hyperkalemia. ● C: Primary hyperaldosteronism typically produces hypertension and hypokalemia. ● D: Cushing syndrome produces cortisol excess.

Cosyntropin stimulates the adrenal cortex. Failure of cortisol to rise appropriately supports adrenal insufficiency. ● A: This evaluates glucose metabolism. ● B: This is used when diabetes insipidus is suspected. ● D: Dexamethasone suppression testing evaluates cortisol excess.

Mineralocorticoid deficiency causes sodium loss and volume depletion, stimulating renin. Damaged adrenal tissue cannot produce an adequate aldosterone response.

Suspected adrenal crisis requires immediate treatment. Cortisol and ACTH specimens may be collected first when this does not delay care.

Proteinuria, dysmorphic red cells, red-cell casts, hypertension and rising creatinine indicate glomerular inflammation in a patient with systemic lupus erythematosus. ● A: A lower UTI does not usually cause red-cell casts. ● B: Stones may cause hematuria but not typically heavy proteinuria and RBC casts. ● C: Diabetic kidney disease usually causes albuminuria without an active nephritic sediment.

Anti-dsDNA is relatively specific for SLE and may rise with active lupus nephritis. ● A: Rheumatoid factor is not specific and occurs in several conditions. ● C: Antimitochondrial antibody is associated with primary biliary cholangitis. ● D: Anti-centromere antibody is associated with limited cutaneous systemic sclerosis.

Active immune-complex disease may consume complement and produce increasing anti-dsDNA levels.

The patient has evidence of active glomerulonephritis and declining renal function. Renal biopsy may be required to classify the nephritis and guide therapy.

Fever, flank pain, costovertebral-angle tenderness and white-cell casts indicate upper urinary-tract infection. ● A: Cystitis causes lower urinary symptoms but not usually fever, flank pain or WBC casts. ● C: Nephrotic syndrome causes heavy proteinuria, edema and hypoalbuminemia. ● D: Interstitial cystitis is generally a chronic pain syndrome without bacteriuria.

A properly collected midstream sample reduces contamination. Culture should ideally be collected before antimicrobial treatment when this does not delay necessary care.

White-cell casts form within renal tubules and suggest renal parenchymal involvement, as seen in pyelonephritis or interstitial nephritis.

Mixed organisms and abundant squamous epithelial cells suggest a poorly collected or contaminated specimen.

A fourth-generation assay detects both HIV antibodies and p24 antigen and can identify infection earlier than antibody-only tests. ● A: Western blot is no longer the preferred initial screening method. ● B: CD4 count assesses immune status after infection is identified; it is not a screening test. ● D: A throat culture does not evaluate suspected acute HIV infection. The fourth-generation screening assay is reactive, but the HIV-1/HIV-2 antibody differentiation assay is negative.

A reactive screening test with a negative or indeterminate antibody differentiation test may indicate very early infection. HIV RNA testing helps distinguish acute infection from a false-positive screen.

Detectable HIV RNA with a reactive antigen-antibody screen and negative differentiation assay is consistent with acute infection during early seroconversion.

Early specialist assessment and antiretroviral treatment are indicated. The patient should receive counselling regarding transmission risk while confirmatory evaluation and treatment proceed.

The presence of HBsAg and IgM anti-HBc with absent anti-HBs is characteristic of acute hepatitis B infection. ● A: Vaccination produces anti-HBs without anti-HBc. ● B: Resolved infection produces anti-HBc and anti-HBs with absent HBsAg. ● C: Chronic infection generally has persistent HBsAg and total anti-HBc but not IgM anti-HBc, although IgM may occasionally reappear during severe flares.

Vaccination exposes the immune system to surface antigen rather than the core antigen. Therefore, vaccinated individuals develop anti-HBs but not anti-HBc.

Resolved natural infection leaves antibodies to both surface and core antigens.

A reactive HCV antibody indicates exposure but does not distinguish active from resolved infection. Detectable HCV RNA confirms current infection.

Hematuria, red-cell casts, hypertension, reduced GFR and moderate proteinuria constitute a nephritic pattern. ● B: Nephrotic syndrome is characterized by heavy proteinuria, hypoalbuminemia and edema with a relatively bland sediment. ● C: Prerenal azotemia usually produces a bland, concentrated urinary sediment. ● D: Lower UTI does not cause red-cell casts.

Red-cell casts form in renal tubules when erythrocytes enter the nephron through damaged glomeruli.

Poststreptococcal glomerulonephritis commonly produces transient hypocomplementemia and evidence of a recent group A streptococcal infection.

Pulmonary edema, severe hypertension, oliguria and rapidly declining renal function require emergency management.

Recent antimicrobial exposure followed by frequent watery diarrhea, abdominal pain and leukocytosis is characteristic of C. difficile infection. ● A: Irritable bowel syndrome does not usually cause fever or leukocytosis. ● B: Lactose intolerance causes osmotic symptoms without systemic inflammatory findings. ● D: Pancreatic insufficiency more commonly causes chronic greasy or bulky stools.

Testing should generally be limited to patients with clinically significant unexplained diarrhea. Formed stool should not routinely be tested.

Patients may remain colonized and continue to test positive after clinical recovery. Routine test-of-cure testing is therefore not generally useful.

These findings suggest severe or fulminant infection with risk of toxic megacolon, shock and organ failure.

A suspicious pigmented lesion should generally be removed with a full-thickness diagnostic biopsy that permits accurate assessment of lesion depth. ● A: Serum tumour markers do not diagnose primary cutaneous melanoma. ● C: Evolution and bleeding require prompt investigation. ● D: Fungal testing does not evaluate a potentially malignant pigmented lesion.

Breslow thickness measures the vertical depth of invasion and is a major determinant of staging, prognosis and subsequent management.

Melanoma in situ is confined to the epidermis but still requires complete excision to prevent local progression.

A clinically suspicious lesion with a melanoma diagnosis requires timely specialist management.

Chest radiography is the usual initial imaging study when pneumonia is suspected. It can demonstrate consolidation, pleural effusion, atelectasis or an alternative diagnosis. ● A: MRI is not routinely used for initial pneumonia evaluation. ● C: PET-CT is generally used for selected malignancy and inflammatory assessments. ● D: A ventilation-perfusion scan is primarily used when pulmonary embolism is suspected and CT pulmonary angiography is unsuitable. A chest radiograph demonstrates dense right-lower-lobe airspace opacity with visible air bronchograms.

Focal airspace opacity with air bronchograms is consistent with alveolar filling and lobar pneumonia.

Blunting of the costophrenic angle commonly indicates pleural-fluid accumulation.

Thoracic ultrasound can characterize pleural fluid, identify septations and guide diagnostic thoracentesis.

Unilateral absent breath sounds, hypotension, respiratory distress and mediastinal displacement following trauma strongly indicate tension pneumothorax.

Tension pneumothorax is a clinical emergency. Treatment should not be delayed for radiographic confirmation in an unstable patient.

A chest radiograph can show a visible pleural line with absent peripheral lung markings.

Loss of pleural sliding may support pneumothorax, although interpretation requires clinical context and operator skill.

Prior abdominal surgery raises concern for adhesions. Colicky pain, vomiting, distension and obstipation are typical of mechanical obstruction.

CT can determine the transition point, cause and complications such as ischemia, perforation or closed-loop obstruction.

Mechanical obstruction can produce dilated small-bowel loops and multiple air-fluid levels, although CT provides more complete assessment. The patient develops sudden severe generalized pain, guarding and rigidity. An upright chest radiograph shows free air beneath the diaphragm.

Free intraperitoneal air with peritoneal signs indicates probable gastrointestinal perforation requiring urgent surgical management.

Ultrasonography is the preferred initial imaging study for suspected gallstones and acute cholecystitis.

Supportive findings include cholelithiasis, gallbladder-wall thickening, distension, pericholecystic fluid and focal tenderness when the probe presses over the gallbladder.

A HIDA scan evaluates cystic-duct patency. Failure of the gallbladder to visualize supports acute cholecystitis.

Obstruction accompanied by systemic infection and organ dysfunction requires urgent antimicrobial treatment, stabilization and biliary drainage.

Pregnancy location should be evaluated using quantitative hCG together with transvaginal ultrasound. Transvaginal ultrasonography shows no intrauterine pregnancy and no definite adnexal mass.

A positive pregnancy test without a pregnancy identified inside or outside the uterus is classified as a pregnancy of unknown location until follow-up establishes the diagnosis.

The trend in hCG and repeat imaging help differentiate an early intrauterine pregnancy, failing pregnancy and ectopic pregnancy. The patient later develops severe pain, syncope, hypotension and free pelvic fluid on ultrasound.

Hemodynamic instability and free fluid suggest ruptured ectopic pregnancy with intra-abdominal bleeding.

Compression ultrasound is the principal initial imaging test for suspected lower-extremity DVT.

A thrombosed vein does not collapse normally under transducer pressure.

A single negative proximal ultrasound may not detect an early or distal thrombus. Repeat assessment is appropriate when suspicion remains high. The patient suddenly develops pleuritic chest pain, tachycardia and hypoxemia.

CT pulmonary angiography directly evaluates the pulmonary arteries for emboli.

The immediate purpose of noncontrast CT is to identify intracranial hemorrhage and other major contraindications to reperfusion treatment. The CT shows no hemorrhage.

CT angiography evaluates intracranial and extracranial arteries for large-vessel occlusion.

Restricted diffusion can identify acute ischemic injury early, sometimes before changes are apparent on noncontrast CT.

Stroke treatment is highly time dependent. Imaging should answer immediate management questions without creating avoidable delays.

Noncontrast CT is highly sensitive for urinary calculi and can identify stone size, location and obstruction.

Ultrasound avoids ionizing radiation and can identify hydronephrosis, although it may not directly visualize every ureteral stone.

Dilation of the renal collecting system indicates impaired urine drainage. The patient develops fever, hypotension and pyuria. CT demonstrates an obstructing proximal ureteral stone with hydronephrosis.

An infected obstructed urinary system is a urologic emergency because antibiotics may not adequately control infection without drainage.

MRI provides detailed evaluation of the spinal canal, nerve roots, discs, epidural space and other compressive lesions.

Radiographs can assess bones and alignment but do not adequately visualize the cauda equina, intervertebral discs or epidural lesions.

CT myelography can evaluate spinal canal compression when MRI cannot be performed, although it is invasive and uses ionizing radiation and intrathecal contrast.

Cauda equina syndrome requires urgent decompression assessment to reduce the risk of permanent bladder, bowel, sexual and neurologic dysfunction.

A spiculated mass, lymphadenopathy, smoking history, hemoptysis and weight loss are concerning for lung cancer.

PET-CT helps stage many cancers by identifying metabolically active lymph nodes and distant lesions. Inflammatory and infectious processes can also produce increased uptake.

Imaging may strongly suggest malignancy, but tissue is generally required to determine histologic type and guide treatment.

Contrast-enhanced brain MRI is sensitive for detecting intracranial metastatic lesions.

ST elevation in leads II, III and aVF localizes acute myocardial injury to the inferior wall. Reciprocal depression in I and aVL strengthens the diagnosis of acute coronary occlusion rather than a diffuse ST-segment process.

Inferior infarction with right-ventricular involvement most commonly results from proximal right coronary artery occlusion. Right-ventricular failure can produce hypotension and elevated venous pressure without pulmonary congestion.

Right-sided leads help identify right-ventricular infarction. ST elevation in V4R is particularly supportive when an inferior STEMI is accompanied by hypotension and clear lung fields.

Troponin may not yet be elevated early after coronary occlusion. A diagnostic STEMI pattern with compatible symptoms requires immediate management and should not be delayed while awaiting biomarker elevation.

A right-ventricular infarction may produce preload-dependent circulation. Nitroglycerin can reduce venous return and worsen severe hypotension in this setting.

Acute STEMI requires immediate emergency treatment and rapid evaluation for primary percutaneous coronary intervention. Unnecessary investigations should not delay reperfusion.

Atrial fibrillation is characterized by irregularly irregular ventricular activation and absence of consistent, organized P waves. ECG documentation should be visually confirmed before establishing the diagnosis.

Echocardiography evaluates atrial size, ventricular function, valvular abnormalities and other structural conditions that can contribute to atrial fibrillation.

Monitoring duration should match symptom frequency. A multiday patch or event monitor is more likely than a short routine ECG to document intermittent episodes occurring every several days.

Electrolyte abnormalities and thyroid disease can precipitate or aggravate atrial arrhythmias and should be considered during the initial assessment.

Atrial fibrillation management includes assessment of stroke risk, consideration of anticoagulation, symptom control and management of contributing conditions.

An unstable tachyarrhythmia causing hypotension, acute heart failure or altered consciousness requires immediate synchronized cardioversion.

Complete AV block is present when atrial and ventricular activity occur independently because no atrial impulses are consistently conducted to the ventricles.

Independent P-wave and QRS activity demonstrates AV dissociation. A ventricular escape rhythm maintains a slow ventricular rate.

AV block may be associated with medications, ischemia, electrolyte disturbances, infection or structural conduction-system disease. Reversible contributors should be investigated promptly.

Symptomatic high-grade bradycardia with hypotension and syncope requires emergency management. Transcutaneous pacing may be used while preparing for more definitive pacing.

Permanent pacing is recommended for acquired Mobitz II, high-grade or third-degree AV block not attributable to a reversible or physiologic cause.

Continuous monitoring is required because complete heart block can deteriorate into prolonged pauses, unstable escape rhythms or cardiac arrest.

The combined effects of QT-prolonging medications, hypokalemia, hypomagnesemia and impaired medication clearance can substantially increase the corrected QT interval.

Torsades is a polymorphic ventricular tachycardia associated with prolonged QT. The QRS morphology appears to twist around the ECG baseline.

Management includes removing QT-prolonging factors, correcting electrolyte abnormalities and reviewing renal function and medication interactions.

Sustained polymorphic VT is electrically unstable and cannot be reliably synchronized. Immediate unsynchronized shock is recommended when the rhythm is sustained or the patient is pulseless.

Intravenous magnesium may suppress recurrent torsades even when the initial serum magnesium concentration is not profoundly reduced.

Monitoring confirms correction of potassium and magnesium and determines whether the QT interval returns toward baseline after the contributing medications are discontinued.

Pleuritic positional chest pain, a friction rub, diffuse ST elevation and PR depression are characteristic of acute pericardial inflammation.

STEMI usually follows an anatomic coronary distribution and may produce localized reciprocal changes. Pericarditis more often causes widespread ST elevation and PR-segment abnormalities.

Echocardiography can identify pericardial fluid and assess whether it is producing hemodynamic compromise. It should be obtained emergently when tamponade is suspected. One week later, the patient develops hypotension, tachycardia, elevated jugular venous pressure and muffled heart sounds.

Tamponade can produce right-sided chamber collapse, respiratory variation in Doppler flow and a plethoric inferior vena cava. The findings must be interpreted together with the patient’s hemodynamic condition.

Electrical alternans refers to beat-to-beat variation in QRS amplitude and may occur when the heart moves within a large effusion.

Hemodynamically significant tamponade requires immediate specialist management and drainage, commonly through image-guided pericardiocentesis.

Echocardiography evaluates chamber dimensions, ventricular systolic and diastolic function, regional wall motion, valves and pericardium. The echocardiogram reports: ● Dilated left ventricle ● Global hypokinesis ● Left-ventricular ejection fraction of 30% ● Functional mitral regurgitation

An LVEF of 30% indicates reduced left-ventricular systolic function and is consistent with HFrEF when accompanied by the clinical syndrome of heart failure.

Ejection fraction is calculated from the difference between end-diastolic and end-systolic ventricular volumes relative to end-diastolic volume.

Regional dysfunction following a coronary distribution raises concern for prior infarction or active ischemic heart disease, whereas global hypokinesis has a broader differential.

HFpEF can occur with normal systolic ejection fraction but abnormal relaxation, elevated filling pressures or other structural abnormalities. Diastolic assessment is therefore an important component of echocardiography.

Repeat imaging is appropriate when symptoms change, a new cardiac event occurs or reassessment of ventricular function will affect treatment or device decisions.

An FEV₁/FVC ratio below the lower limit of normal indicates airflow obstruction. Spirometry is used to diagnose and monitor disorders such as asthma and COPD.

Variable symptoms and substantial improvement in airflow after bronchodilator administration support variable expiratory airflow limitation consistent with asthma.

Airflow obstruction is identified by a reduced relationship between the volume exhaled during the first second and the total forced vital capacity.

A normal baseline study does not exclude intermittent asthma. Bronchial challenge or appropriately supervised exercise testing may identify variable airway hyperresponsiveness.

Repeated peak-flow measurements can help demonstrate day-to-day or exposure-related variation in expiratory airflow.

Formal spirometry should not delay management of a severe acute asthma exacerbation. Immediate assessment and stabilization take priority.

Restriction is confirmed by reduced total lung capacity. A low FVC with a preserved or elevated FEV₁/FVC ratio suggests possible restriction but is not independently diagnostic.

A reduced total lung capacity confirms a restrictive ventilatory defect. Spirometry alone cannot reliably distinguish true restriction from air trapping or submaximal effort.

DLCO may be reduced in interstitial lung disease, emphysema, pulmonary vascular disease and anemia. It must be interpreted with lung volumes and clinical findings.

High-resolution CT can characterize reticulation, ground-glass change, traction bronchiectasis and honeycombing more accurately than standard chest radiography.

Extrapulmonary restriction from obesity, chest-wall disease or neuromuscular weakness may reduce lung volumes while leaving alveolar-capillary gas transfer relatively preserved.

Rapid progression, hypoxemia or substantial exertional desaturation requires expedited assessment for advanced lung disease and potentially reversible complications.

EEG assesses cerebral electrical activity and may identify epileptiform abnormalities that support seizure diagnosis and help classify seizure type. Evaluation of an unprovoked first seizure commonly includes EEG and brain imaging.

Interictal epileptiform discharges increase the probability that the event was epileptic and are associated with an increased risk of recurrence.

Epileptiform activity is intermittent and may not occur during a short routine recording. Repeat, sleep-deprived or prolonged recordings may increase diagnostic yield.

MRI is more sensitive than CT for many structural epileptogenic lesions, including cortical malformations, small tumours and mesial temporal abnormalities.

Video-EEG records the clinical event and simultaneous EEG activity and is useful when epileptic seizures must be distinguished from nonepileptic events.

A prolonged convulsive seizure or recurrent seizures without recovery require immediate airway, circulation, glucose and antiseizure management. Diagnostic testing should not delay stabilization.

Electrodiagnostic testing evaluates the physiologic function of peripheral nerves and muscles and can help distinguish mononeuropathy, radiculopathy, plexopathy and polyneuropathy.

Focal slowing or delayed median-nerve conduction across the carpal tunnel, particularly compared with nearby nerves, supports median neuropathy at the wrist.

Fibrillation potentials, positive sharp waves or reduced recruitment in affected muscles may indicate axonal injury and help assess severity.

A radicular lesion is generally proximal to the dorsal-root ganglion, so distal sensory nerve-action potentials may remain normal. Needle EMG can demonstrate abnormalities in muscles supplied by the affected root.

MRI identifies disc herniation, foraminal stenosis, spinal-cord compression and other structural causes. Electrodiagnostic testing provides complementary physiologic information.

Progressive motor impairment or muscle atrophy suggests significant nerve dysfunction and increases the need for timely specialist assessment.

A positive HPV-16 result indicates increased risk for clinically significant cervical precancer but does not itself establish cancer. HPV-16 and HPV-18 carry the highest risk and generally require additional evaluation even when cytology is negative.

Colposcopy permits magnified examination of the cervix. Suspicious areas can be biopsied to determine whether cervical intraepithelial neoplasia or invasive cancer is present.

Cytology and HPV testing are screening or risk-stratification tools. Histopathologic examination of a biopsy establishes the tissue diagnosis and grade of cervical precancer.

HPV vaccination substantially reduces risk but does not eliminate all oncogenic HPV infection or cervical cancer risk. Vaccinated individuals should continue recommended cervical screening. Current average-risk screening options vary by age and jurisdiction.

Screening recommendations apply to asymptomatic people. Persistent postcoital bleeding is a symptom and requires diagnostic evaluation regardless of the timing or result of the previous screening test.

Immunosuppression, previous high-grade cervical disease, prior cervical cancer and certain prenatal exposures may require individualized surveillance rather than routine average-risk screening.

A patient with a palpable breast abnormality is symptomatic. Imaging is therefore diagnostic rather than routine screening.

Diagnostic mammography evaluates both breasts and permits additional views of the area of concern. Targeted ultrasound helps distinguish solid from cystic lesions and evaluates the palpable region.

A highly suspicious imaging finding requires histopathologic confirmation. Abnormal mammography results must receive appropriate follow-up, including biopsy when indicated.

Core biopsy provides tissue architecture and usually permits assessment of invasive status and tumour biomarkers. It remains a diagnostic procedure and does not necessarily remove the entire lesion.

A negative mammogram does not override a strongly suspicious clinical finding. Clinical, imaging and pathologic findings should be concordant before malignancy is excluded.

The 2024 USPSTF recommendation supports mammography every two years for average-risk women aged 40–74. High-risk individuals may require a different strategy, and guidelines can vary by jurisdiction.

An abnormal stool-based colorectal screening test requires colonoscopy for diagnostic evaluation. Repeating the stool test does not complete the screening pathway.

The benefit of stool-based screening is achieved only when an abnormal result is followed by colonoscopy. A second negative FIT would not reliably explain or exclude the source of the first positive result.

FIT is a noninvasive stool test that uses antibodies to detect blood. Unlike colonoscopy, it neither visualizes the colon nor permits polyp removal.

Screening recommendations are intended for asymptomatic, average-risk patients. Iron-deficiency anemia, weight loss, rectal bleeding or altered bowel habits warrant diagnostic investigation.

Adenoma number, size, architecture, dysplasia and completeness of removal are central to determining subsequent colonoscopic surveillance.

Peritonism, severe pain, fever or hemodynamic changes after colonoscopy may indicate perforation, significant bleeding or post-polypectomy complications and require urgent evaluation.

In postmenopausal women and men aged 50 or older, a T-score of −2.5 or lower at an appropriate central skeletal site is consistent with osteoporosis.

A T-score reports how many standard deviations the measured BMD differs from a young-adult reference mean.

A Z-score compares the patient with an age- and sex-matched reference population and is generally more appropriate in younger patients. A markedly low Z-score raises concern for secondary causes.

Central DXA is the standard bone-density test. Peripheral or heel measurements may estimate risk but do not replace central DXA when a definitive BMD diagnosis is required.

The evaluation should be individualized but may include calcium, creatinine, 25-hydroxyvitamin D, CBC, liver studies, thyroid testing and other investigations based on history.

DXA evaluates bone density; it is not the initial test for acute fracture. Radiographs are obtained first, with MRI or other advanced imaging considered if radiographs are negative but suspicion remains high.

One-time ultrasound screening is recommended for men aged 65–75 who have ever smoked. Ultrasound is noninvasive and accurately measures the abdominal aortic diameter. Ultrasonography identifies a 4.6-cm infrarenal abdominal aortic aneurysm.

An asymptomatic aneurysm that does not meet immediate intervention criteria requires cardiovascular risk management and surveillance based on size, growth and local vascular guidelines.

Ultrasound is well suited to screening and surveillance. CT angiography provides more detailed anatomic information when planning intervention or evaluating complications.

CT angiography demonstrates aneurysm extent, neck anatomy, branch vessels, thrombus and access-vessel anatomy relevant to repair planning.

A known AAA accompanied by sudden abdominal or back pain and shock suggests rupture. Emergency stabilization and vascular management must not be delayed for routine screening procedures.

The USPSTF recommends against routine screening in this low-risk group. Symptomatic patients are not undergoing screening; they require diagnostic assessment.

Cell-free DNA is a highly sensitive screening test for selected aneuploidies, but false-positive and false-negative results can occur. It does not replace diagnostic testing.

The patient should receive counselling about the meaning of the result and be offered chorionic villus sampling or amniocentesis for diagnostic confirmation.

CVS samples placental chorionic villi and can generally be performed earlier in pregnancy than amniocentesis.

Amniocentesis obtains amniotic fluid for fetal chromosomal, genetic or other selected diagnostic testing. It is generally performed later than CVS.

Cell-free DNA evaluates selected chromosomal conditions. It does not identify every genetic, developmental or structural abnormality.

Screening estimates risk. Diagnostic testing provides a more definitive result and should be offered before major irreversible decisions.

Newborn screening identifies infants at increased risk before clinical disease is obvious. An abnormal screen is not the final diagnosis and requires prompt follow-up.

Serum TSH and free T4 determine whether primary hypothyroidism is present and assess its biochemical severity. The confirmatory results show markedly elevated serum TSH and reduced free T4.

A high TSH with a low free T4 indicates failure of the thyroid gland to produce adequate hormone.

Early identification and treatment are central goals of newborn screening because presymptomatic treatment improves outcomes and reduces preventable disability.

Treatment is adjusted using serial thyroid-function testing together with growth, development and clinical assessment.

Prematurity, illness, transfusion and early specimen timing can complicate newborn-screen interpretation and may necessitate repeat testing according to the screening programme.

A serum acetaminophen concentration is used with the time since ingestion to assess hepatotoxicity risk after a single acute ingestion. A concentration drawn too early may not represent complete absorption.

For a known single acute ingestion, a four-hour or later level can be plotted on the Rumack–Matthew nomogram. Earlier levels may underestimate the eventual peak.

N-acetylcysteine replenishes glutathione and helps detoxify the reactive metabolite responsible for hepatic injury. It should be administered promptly when treatment criteria are met.

The nomogram is designed for a single acute ingestion with a known time. Repeated ingestion, unknown timing and delayed or prolonged absorption require assessment using acetaminophen concentration, transaminases and clinical toxicology guidance.

Monitoring assesses continued drug presence, hepatocellular injury, synthetic liver function, renal injury and metabolic complications. N-acetylcysteine should not be stopped solely because a fixed infusion time has elapsed; laboratory and clinical stopping criteria must be assessed.

These findings suggest fulminant hepatic failure. Management requires continued antidotal therapy, critical care and early transplant-centre involvement.

Gastrointestinal symptoms, coarse tremor, ataxia and confusion in a patient taking lithium suggest toxicity. Volume depletion, impaired renal clearance and interacting medications increase risk.

Lithium is cleared primarily through the kidneys. Serum concentration must be interpreted alongside creatinine, sodium, hydration status, symptoms and timing of the last dose.

Trough sampling near 12 hours permits meaningful comparison with the therapeutic target and previous measurements.

Thiazides increase renal sodium loss, leading to increased proximal sodium and lithium reabsorption. Vomiting and dehydration further reduce lithium clearance.

Some patients, especially older adults or those with chronic exposure, can exhibit toxicity at concentrations tolerated by others. Product information cautions against relying on the serum level alone.

Severe neurologic manifestations, renal failure or very high lithium concentrations can require extracorporeal removal in addition to stopping lithium and restoring fluid and electrolyte balance.

Capillary samples can be contaminated by lead on the skin and may produce falsely elevated results. An elevated capillary result should be confirmed with a venous sample, with greater elevations requiring faster confirmation.

Venous testing is more reliable for confirming lower blood lead concentrations and reduces the risk of contamination from lead-containing dust on the skin.

Blood lead testing is the primary clinical method for identifying lead exposure. Hair analysis and nonspecific urine tests are not appropriate substitutes.

Management includes environmental investigation and exposure removal, nutritional assessment, evaluation for iron deficiency, developmental surveillance and serial blood lead testing. Chelation is reserved for selected high-level or symptomatic exposures.

Iron deficiency is common in children with pica and may increase lead absorption. CBC, ferritin and nutritional evaluation are appropriate.

Neurologic manifestations may represent lead encephalopathy. Severe or very high-level exposure requires emergency specialist management, and abdominal imaging may be considered when ingestion of lead-containing material is suspected.